These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Inhibitory effect of hypothalamic medial preoptic area somatostatin on growth hormone-releasing factor in the rat. Katakami H; Downs TR; Frohman LA Endocrinology; 1988 Aug; 123(2):1103-9. PubMed ID: 2899498 [TBL] [Abstract][Full Text] [Related]
43. Somatostatin inhibits basal and vasoactive intestinal peptide-stimulated hormone release by different mechanisms in GH pituitary cells. Dorflinger LJ; Schonbrunn A Endocrinology; 1983 Nov; 113(5):1551-8. PubMed ID: 6138245 [TBL] [Abstract][Full Text] [Related]
44. Physiologically significant effect of neuropeptide Y to suppress growth hormone release by stimulating somatostatin discharge. Rettori V; Milenkovic L; Aguila MC; McCann SM Endocrinology; 1990 May; 126(5):2296-301. PubMed ID: 1970290 [TBL] [Abstract][Full Text] [Related]
45. In vivo studies of somatostatin-14 and somatostatin-28 biosynthesis in rat hypothalamus. Van Itallie CM; Fernstrom JD Endocrinology; 1983 Oct; 113(4):1210-7. PubMed ID: 6137359 [TBL] [Abstract][Full Text] [Related]
46. Evidence that growth hormone-releasing factor stimulates somatostatin release in vitro via beta-endorphin. Aguila MC; McCann SM Endocrinology; 1987 Jan; 120(1):341-4. PubMed ID: 2877865 [TBL] [Abstract][Full Text] [Related]
47. Combined effects of human growth hormone (GH)-releasing factor-44 (GRF) and somatostatin (SRIF) on post-SRIF rebound release of GH and prolactin: a model for GRF-SRIF modulation of secretion. Stachura ME; Tyler JM; Farmer PK Endocrinology; 1988 Sep; 123(3):1476-82. PubMed ID: 2900135 [TBL] [Abstract][Full Text] [Related]
48. Reciprocal interactions of somatostatin with thyrotropin-releasing hormone and vasoactive intestinal peptide on prolactin and growth hormone secretion in vitro. Enjalbert A; Epelbaum J; Arancibia S; Tapia-Arancibia L; Bluet-Pajot MT; Kordon C Endocrinology; 1982 Jul; 111(1):42-7. PubMed ID: 6123432 [TBL] [Abstract][Full Text] [Related]
49. Further studies on the effect of glucose concentrations and other oxidizable substrates upon ionic gradients and in vitro somatostatin release from rat mediobasal hypothalamus. Joanny P; Steinberg J; Conte-Devolx B; Oliver C Neurosci Lett; 1987 Nov; 82(1):65-70. PubMed ID: 2892159 [TBL] [Abstract][Full Text] [Related]
50. Signal transduction systems in growth hormone-releasing hormone and somatostatin release from perifused rat hypothalamic fragments. Cugini CD; Millard WJ; Leidy JW Endocrinology; 1991 Sep; 129(3):1355-62. PubMed ID: 1678698 [TBL] [Abstract][Full Text] [Related]
51. Effect of fetal ethanol exposure on the in vitro release of growth hormone, somatostatin and growth hormone-releasing factor induced by clonidine and growth hormone feedback in male and female rats. Conway S; Ling SY; Leidy JW; Blaine K; Holtzman T Alcohol Clin Exp Res; 1997 Aug; 21(5):826-39. PubMed ID: 9267532 [TBL] [Abstract][Full Text] [Related]
52. Stimulation of somatostatin release from median eminence tissue incubated in vitro by taurine and related amino acids. Aguila MC; McCann SM Endocrinology; 1985 Mar; 116(3):1158-62. PubMed ID: 2857639 [TBL] [Abstract][Full Text] [Related]
53. Characterisation of somatostatin and TRH release by rat hypothalamic and cerebral cortical neurons maintained on a capillary membrane perfusion system. Scanlon MF; Robbins RJ; Bolaffi JL; Jackson IM; Reichlin S Neuroendocrinology; 1983 Oct; 37(4):269-74. PubMed ID: 6138723 [TBL] [Abstract][Full Text] [Related]
54. Quantitative analysis of the change of metabolite fluxes along the pentose phosphate and glycolytic pathways in Tetrahymena in response to carbohydrates. Borowitz MJ; Stein RB; Blum JJ J Biol Chem; 1977 Mar; 252(5):1589-605. PubMed ID: 402368 [TBL] [Abstract][Full Text] [Related]
55. Differential production of SRIF 14 and 28 by fetal rat hypothalamic cells enriched by velocity sedimentation. Lewis MD; Foord SM; Lewis MB; Hall R; Scanlon MF Neuroendocrinology; 1986; 44(1):125-31. PubMed ID: 2878383 [TBL] [Abstract][Full Text] [Related]
56. Establishment of a radioimmunoassay of somatostatin in human plasma and in rat hypothalamus. Ho LT; Lam HC; Wang JT; Tang KT; Perng JC; Liu YF; Chen RL Chin J Physiol; 1986; 29(2):91-103. PubMed ID: 2884084 [TBL] [Abstract][Full Text] [Related]
57. A dual role of calcium in release of somatostatin from canine gastric antral mucosa. Pittenger G; Vinik AI; Fiddian-Green RG; Wagner L Am J Physiol; 1984 Apr; 246(4 Pt 1):E361-8. PubMed ID: 6144272 [TBL] [Abstract][Full Text] [Related]
58. Effects of glycolytic metabolites on preservation of high energy phosphate level and synaptic transmission in the granule cells of guinea pig hippocampal slices. Kanatani T; Mizuno K; Okada Y Experientia; 1995 Mar; 51(3):213-6. PubMed ID: 7698281 [TBL] [Abstract][Full Text] [Related]
59. Glucose-induced changes in somatostatin-14 and somatostatin-28 released from rat hypothalamic fragments 'in vitro'. Lengyel AM; Nieuwenhuyzen Kruseman AC; Grossman A; Rees LH; Besser GM Life Sci; 1984 Aug; 35(7):713-9. PubMed ID: 6147741 [TBL] [Abstract][Full Text] [Related]
60. Enhancing effect of saccharides on the mutagenicity of 2-chloro-4-methylthiobutanoic acid. Kimura S; Arimoto-Kobayashi S; Hayatsu H Mutat Res; 2000 Jul; 452(1):139-44. PubMed ID: 10894898 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]